Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Cheresh

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Trends in Cell Biology|August 28, 2023
Tumor-initiating cells establish a niche to overcome isolation stressChengsheng Wu, Sara M Weis, David A Cheresh
Oncoscience|March 21, 2018
Re-thinking the preclinical development of GBM therapeuticsÉrika Cosset, Sara M Weis, David A Cheresh
Cell Stem Cell|May 6, 2014
Variety in the tumor microenvironment: integrin splicing regulates stemnessLaetitia Seguin, Sara M Weis, David A Cheresh
Journal of Cell Science|October 23, 2023
Upregulation of fibronectin and its integrin receptors - an adaptation to isolation stress that facilitates tumor initiationChengsheng Wu, Sara M Weis, David A Cheresh
The Journal of Biological Chemistry|July 20, 2005
Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal stateMatthew D Potter, Simone Barbero, David A Cheresh
Cancer Metastasis Reviews|November 7, 2020
Metastasis is a highly stressful processAlejandro D Campos, Sara M Weis, David A Cheresh
Current Protocols in Stem Cell Biology|March 5, 2010
Derivation of vasculature from embryonic stem cellsJeffrey N Lindquist, David A Cheresh, Evan Y Snyder
Nature Medicine|April 9, 2008
Robo4 counteracts VEGF signalingLisette M Acevedo, Sara M Weis, David A Cheresh
Cancer Cell|May 5, 2009
Agonizing integrin antagonists?Sara M Weis, Dwayne G Stupack, David A Cheresh
Neuroscience Letters|January 23, 2017
Treatment of rats with the JAK-2 inhibitor fedratinib does not lead to experimental Wernicke's encephalopathyAlan S Hazell, Szeifoul Afadlal, David A Cheresh, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Trends in Cell Biology|August 28, 2023
Tumor-initiating cells establish a niche to overcome isolation stressChengsheng Wu, Sara M Weis, David A Cheresh
Oncoscience|March 21, 2018
Re-thinking the preclinical development of GBM therapeuticsÉrika Cosset, Sara M Weis, David A Cheresh
Cell Stem Cell|May 6, 2014
Variety in the tumor microenvironment: integrin splicing regulates stemnessLaetitia Seguin, Sara M Weis, David A Cheresh
Journal of Cell Science|October 23, 2023
Upregulation of fibronectin and its integrin receptors - an adaptation to isolation stress that facilitates tumor initiationChengsheng Wu, Sara M Weis, David A Cheresh
The Journal of Biological Chemistry|July 20, 2005
Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal stateMatthew D Potter, Simone Barbero, David A Cheresh
Cancer Metastasis Reviews|November 7, 2020
Metastasis is a highly stressful processAlejandro D Campos, Sara M Weis, David A Cheresh
Current Protocols in Stem Cell Biology|March 5, 2010
Derivation of vasculature from embryonic stem cellsJeffrey N Lindquist, David A Cheresh, Evan Y Snyder
Nature Medicine|April 9, 2008
Robo4 counteracts VEGF signalingLisette M Acevedo, Sara M Weis, David A Cheresh
Cancer Cell|May 5, 2009
Agonizing integrin antagonists?Sara M Weis, Dwayne G Stupack, David A Cheresh
Neuroscience Letters|January 23, 2017
Treatment of rats with the JAK-2 inhibitor fedratinib does not lead to experimental Wernicke's encephalopathyAlan S Hazell, Szeifoul Afadlal, David A Cheresh, et al.
Pageof 10